EGFR-driven behavior and intrapatient T790M mutation heterogeneity of non-small-cell carcinoma with squamous histology

Journal of Clinical Oncology

Volumn 33, Issue 31, 2015, Pages e115-e118

  Graziano, Paolo ^a   De Marinis, Filippo ^a   Gori, Bruno ^a   Gasbarra, Rita ^a   Migliorino, Rita ^a   De Santis, Stefano ^a   Pelosi, Giuseppe ^b   Leone, Alvaro ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PROTEIN P40; PROTEIN P63; PROTEIN TYROSINE KINASE INHIBITOR; ZOLEDRONIC ACID; EGFR PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; BACKACHE; BONE PAIN; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; DYSPNEA; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC HETEROGENEITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER METASTASIS; LOW BACK PAIN; LUNG BIOPSY; LUNG LESION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SPINAL CORD METASTASIS; SQUAMOUS CELL LUNG CARCINOMA; TUMOR BIOPSY; ADENOCARCINOMA; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENETIC VARIATION; GENETICS; LIVER TUMOR; LUNG TUMOR; MUTATION; NON SMALL CELL LUNG CANCER; PATHOLOGY; RADIOGRAPHY; SECONDARY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE DELETION; GENETIC VARIATION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84947239975     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.5697     Document Type: Article

References (12)

1. Miyamae Y, Shimizu K, Hirato J, et al: Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma. Oncol Rep 25:921-928, 2011
2. Perez-Moreno P, Brambilla E, Thomas R, et al: Squamous cell carcinoma of the lung: Molecular subtypes and therapeutic opportunities. Clin Cancer Res 18:2443-2451, 2012
3. Baik CS, Pritchard CC, Eaton KD, et al: EGFR mutations in squamous cell ung cancer in never-smokers. J Thorac Oncol 8:e6-e7, 2013
4. Pelosi G, Fabbri A, Bianchi F, et al: ANp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cel ung cancer: A novel two-hit, sparing-material approach. J Thorac Oncol 7:281-290, 2012
5. Rekhtman N, Paik PK, Arcila ME, et al: Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of the lung: Lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin Cancer Res 18:1167-1176, 2012
6. Godin-Heymann N, Bryant I, Rivera MN, et al: Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation. Cancer Res 67:7319-7326, 2007
7. Tanaka K, Hata A, Kida Y, et al: Gefitinib for a poor performance status patient with squamous cell carcinoma of the lung harboring EGFR mutation. Intern Med 51:659-661, 2012
8. Iwanaga K, Sueoka-Aragane N, Nakamura T, et al: The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib. Intern Med 51:2771-2774, 2012
9. Paik PK, Varghese AM, Sima CS, et al: Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component. Mol Cancer Ther 11:2535-2540, 2012
10. Tseng JS, Yang TY, Chen KC, et al: Retrospective study of erlotinib in patients with advanced squamous lung cancer. Lung Cancer 77:128-133, 2012
11. Hata A, Katakami N, Yoshioka H, et al: How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations? J Thorac Oncol 8:89-95, 2013
12. de Marinis F, Rossi A, Di Maio M, et al: Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines. Lung Cancer 73:1-10, 2011